Skip Navigation

ACS is committed to helping combat the global COVID-19 pandemic with initiatives and free resources. Learn More

Faraj Atassi

Faraj Atassi is a registered pharmacist and holds a Master’s degree in medicinal chemistry from Philadelphia College of Pharmacy and a PhD in Industrial and Physical Pharmacy from Purdue University. Faraj held pharmaceutical development positions at Eli Lilly and Novartis; currently he is the Pharmaceutical Science Team Lead at AstraZeneca, Boston. He was also the director of formulation and CMC and analytical development at Sage therapeutics and at Pulmatrix, respectively. He has numerous peer-reviewed articles and presented at U.S. and international conferences.